{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:30:04Z","timestamp":1761183004948,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.jiac.2020.05.001","type":"journal-article","created":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T07:43:54Z","timestamp":1591170234000},"page":"1054-1057","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical usefulness of very high serum soluble interleukin-2 receptor levels for the detection of tuberculous peritonitis in a patient with chronic myelogenous leukemia"],"prefix":"10.1016","volume":"26","author":[{"given":"Makoto","family":"Moriguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Nanno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiko","family":"Nakane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waki","family":"Imoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4766-9380","authenticated-orcid":false,"given":"Koichi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6251-1696","authenticated-orcid":false,"given":"Hiroshi","family":"Kakeya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Hino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohisa","family":"Nakamae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2020.05.001_bib1","first-page":"140","article-title":"Diagnostic and therapeutic strategies for peritoneal tuberculosis: a review","volume":"7","author":"Wu","year":"2019","journal-title":"J\u00a0Clin Transl Hepatol"},{"key":"10.1016\/j.jiac.2020.05.001_bib2","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.TNMI7-0006-2016","article-title":"Tuberculous peritonitis","volume":"5","author":"Vaid","year":"2017","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jiac.2020.05.001_bib3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/10428190500395472","article-title":"Non-hodgkin lymphoma with high adenosine deaminase levels mimicking peritoneal tuberculosis: an unusual presentation","volume":"47","author":"Buyukberber","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jiac.2020.05.001_bib4","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/dc.21551","article-title":"T-cell lymphoma with raised serum glycoprotein-125(ca-125) and raised ascitic fluid adenosinedeaminase levels initially presenting as ascites: a case report and review of literature","volume":"39","author":"Bihari","year":"2011","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jiac.2020.05.001_bib5","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1200\/JCO.2011.38.2101","article-title":"Prognostic index for acute- and lymphoma-type adult t-cell leukemia\/lymphoma","volume":"30","author":"Katsuya","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jiac.2020.05.001_bib6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3109\/10428199209049799","article-title":"Serum soluble interleukin-2 receptor levels are associated with clinical disease status and histopathological grade in non-hodgkin's lymphoma and chronic lymphocytic leukemia","volume":"7","author":"Barak","year":"1992","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jiac.2020.05.001_bib7","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"Hlh-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jiac.2020.05.001_bib8","doi-asserted-by":"crossref","first-page":"619","DOI":"10.7326\/0003-4819-113-8-619","article-title":"The soluble interleukin-2 receptor: biology, function, and clinical application","volume":"113","author":"Rubin","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jiac.2020.05.001_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1155\/S0962935193000018","article-title":"Biological significance of soluble il-2 receptor","volume":"2","author":"Caruso","year":"1993","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.jiac.2020.05.001_bib10","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0022-3476(05)81610-5","article-title":"Serum-soluble interleukin-2 receptor levels in kawasaki disease","volume":"116","author":"Lang","year":"1990","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jiac.2020.05.001_bib11","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/ard.50.10.706","article-title":"Serum soluble interleukin 2 receptor in systemic lupus erythematosus: effects of disease activity and infection","volume":"50","author":"Wong","year":"1991","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jiac.2020.05.001_bib12","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0896-8411(88)90005-4","article-title":"Serum interleukin-2-receptor in rheumatoid arthritis: a prognostic indicator of disease activity?","volume":"1","author":"Wood","year":"1988","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jiac.2020.05.001_bib13","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1182\/blood.V73.8.2128.2128","article-title":"Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndromes","volume":"73","author":"Komp","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.jiac.2020.05.001_bib14","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.4049\/jimmunol.139.11.3802","article-title":"Activated lymphocytes during acute epstein-barr virus infection","volume":"139","author":"Tomkinson","year":"1987","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jiac.2020.05.001_bib15","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1172\/JCI115457","article-title":"Activation of t lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble cd4, soluble cd8, interleukin 2, and interferon-gamma in sera of children with dengue","volume":"88","author":"Kurane","year":"1991","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jiac.2020.05.001_bib16","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/hep.1840100606","article-title":"Soluble interleukin 2 receptor in acute viral hepatitis and chronic liver disease","volume":"10","author":"M\u00fcller","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.jiac.2020.05.001_bib17","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2169\/internalmedicine.49.3760","article-title":"A\u00a0case of tuberculous peritonitis in a hemodialysis patient with high serum soluble interleukin-2 receptor and ca-125 levels","volume":"49","author":"Kuno","year":"2010","journal-title":"Intern Med"},{"key":"10.1016\/j.jiac.2020.05.001_bib18","first-page":"10","article-title":"Soluble serum interleukin 2 receptor levels in leprosy patients","volume":"69","author":"Tung","year":"1987","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jiac.2020.05.001_bib19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2249.1992.tb07932.x","article-title":"The significance of serum soluble il-2 receptor as a marker for active visceral leishmaniasis in Sicilian patients","volume":"90","author":"Vitale","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jiac.2020.05.001_bib20","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1365-2249.1993.tb05930.x","article-title":"Soluble plasma il-2 receptors and malaria","volume":"91","author":"Riley","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jiac.2020.05.001_bib21","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1164\/ajrccm\/140.3.789","article-title":"Dynamic changes in soluble interleukin-2 receptor levels after lung or heart-lung transplantation","volume":"140","author":"Lawrence","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jiac.2020.05.001_bib22","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0140-6736(89)91368-8","article-title":"Soluble interleukin-2 receptors in serum and bile of liver transplant recipients","volume":"1","author":"Adams","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2020.05.001_bib23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00007890-199201000-00006","article-title":"A\u00a0multicenter study to evaluate a novel assay for quantitation of soluble interleukin 2 receptor in renal transplant recipients","volume":"53","author":"Schroeder","year":"1992","journal-title":"Transplantation"},{"key":"10.1016\/j.jiac.2020.05.001_bib24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0090-1229(89)90020-2","article-title":"Increase of serum interleukin 2 receptor level in thermally injured patients","volume":"51","author":"Teodorczyk-Injeyan","year":"1989","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.jiac.2020.05.001_bib25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ajh.2830190106","article-title":"Adenosine deaminase (ada) in leukemia: clinical value of plasma ada activity and characterization of leukemic cell ada","volume":"19","author":"Morisaki","year":"1985","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jiac.2020.05.001_bib26","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/bcp.12496","article-title":"Metabolism-related pharmacokinetic drug-drug interactions with tyrosine kinase inhibitors: current understanding, challenges and recommendations","volume":"79","author":"Teo","year":"2015","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.jiac.2020.05.001_bib27","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4065\/mcp.2010.0820","article-title":"Current concepts in the management of tuberculosis","volume":"86","author":"Sia","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jiac.2020.05.001_bib28","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.2169\/internalmedicine.49.3659","article-title":"Impact of peripheral lymphocyte count on the sensitivity of 2 IFN-gamma release assays, QFT-G and ELISPOT, in patients with pulmonary tuberculosis","volume":"49","author":"Komiya","year":"2010","journal-title":"Intern Med"},{"key":"10.1016\/j.jiac.2020.05.001_bib29","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3389\/fimmu.2017.00469","article-title":"Immune effector recovery in chronic myeloid leukemia and treatment-free remission","volume":"8","author":"Hughes","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jiac.2020.05.001_bib30","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/79526","article-title":"Evidence that specific t lymphocytes may participate in the elimination of chronic myelogenous leukemia","volume":"6","author":"Molldrem","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.jiac.2020.05.001_bib31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1155\/MI.2005.121","article-title":"On the role of sil-2r measurements in rheumatoid arthritis and cancers","volume":"2005","author":"Witkowska","year":"2005","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.jiac.2020.05.001_bib32","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1164\/ajrccm\/144.2.458","article-title":"T\u00a0lymphocyte activation in patients with active tuberculosis","volume":"144","author":"Chan","year":"1991","journal-title":"Am Rev Respir Dis"},{"issue":"2","key":"10.1016\/j.jiac.2020.05.001_bib33","first-page":"191","article-title":"A\u00a0case of tuberculosis pleuritis with high serum soluble IL-2 receptor","volume":"42","author":"Fujiwara","year":"2004","journal-title":"Nihon Koky\u016bki Gakkai zasshi \u2013 J Jpn Respir Soc"},{"key":"10.1016\/j.jiac.2020.05.001_bib34","first-page":"975","article-title":"Diagnosis of tuberculous pleuritis by the measurement of soluble interleukin 2 receptor in pleural fluid","volume":"4","author":"Porcel","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jiac.2020.05.001_bib35","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1182\/blood-2003-11-3922","article-title":"Elevated serum-soluble interleukin-2 receptor levels in patients with anaplastic large cell lymphoma","volume":"104","author":"Janik","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jiac.2020.05.001_bib36","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1002\/1097-0142(19940601)73:11<2753::AID-CNCR2820731117>3.0.CO;2-X","article-title":"Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult t-cell leukemia","volume":"73","author":"Kamihira","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.jiac.2020.05.001_bib37","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1182\/blood.V74.3.1052.1052","article-title":"Elevated serum-soluble interleukin-2 receptor (tac antigen) levels in chronic myelogenous leukemia patients with blastic crisis","volume":"74","author":"Motoi","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.jiac.2020.05.001_bib38","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1001\/archinternmed.2008.581","article-title":"Peritoneal tuberculosis after imatinib therapy","volume":"169","author":"Senn","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jiac.2020.05.001_bib39","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4103\/0028-3886.84354","article-title":"Meningeal tuberculoma mimicking chloroma in a patient with chronic myeloid leukemia on imatinib","volume":"59","author":"Salunke","year":"2011","journal-title":"Neurol India"},{"key":"10.1016\/j.jiac.2020.05.001_bib40","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1183\/09031936.00025408","article-title":"Tuberculosis complicating imatinib treatment for chronic myeloid leukaemia","volume":"33","author":"Daniels","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2020.05.001_bib41","first-page":"65","article-title":"Diseases at the crossroads: chronic myelogenous leukemia and tuberculosis","volume":"18","author":"Bhatnagar","year":"2015","journal-title":"Arch Iran Med"},{"key":"10.1016\/j.jiac.2020.05.001_bib42","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/ard.2004.021378","article-title":"Chronic myeloid leukaemia and tuberculosis in a patient with rheumatoid arthritis treated with infliximab","volume":"64","author":"Broussais","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jiac.2020.05.001_bib43","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1182\/blood-2007-04-084814","article-title":"Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits t-cell activation and proliferation","volume":"111","author":"Schade","year":"2008","journal-title":"Blood"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X20301574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X20301574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:00:44Z","timestamp":1761159644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X20301574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1341321X20301574"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2020.05.001","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical usefulness of very high serum soluble interleukin-2 receptor levels for the detection of tuberculous peritonitis in a patient with chronic myelogenous leukemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2020.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}